A share price of Cardiol Therapeutics Inc [CRDL] is currently trading at $1.08, down -0.92%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CRDL shares have lost -7.69% over the last week, with a monthly amount drifted -27.52%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cardiol Therapeutics Inc [NASDAQ: CRDL] stock has seen the most recent analyst activity on June 02, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $9. Previously, Rodman & Renshaw started tracking the stock with Buy rating on January 28, 2025, and set its price target to $7. On June 26, 2024, ROTH MKM initiated with a Buy rating and assigned a price target of $10 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $9 on April 22, 2024.
Cardiol Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.77 and $2.63. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Cardiol Therapeutics Inc [NASDAQ: CRDL] shares were valued at $1.08 at the most recent close of the market. An investor can expect a potential return of 640.74% based on the average CRDL price forecast.
Analyzing the CRDL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.88, Equity is -2.33 and Total Capital is -2.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0567 points at the first support level, and at 1.0333 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1067, and for the 2nd resistance point, it is at 1.1333.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cardiol Therapeutics Inc [NASDAQ:CRDL] is 2.46. In addition, the Quick Ratio stands at 2.46 and the Cash Ratio stands at 2.27.
